Investment firm Francisco Partners will acquire IBM’s Watson Health’s data and analytics assets – including Micromedex, MarketScan, and Clinical Development – for an undisclosed price.
[Editor's note: On 30 June, Francisco health announced that the new company formed out of the Watson Health assets is called Merative and will be based in Ann Arbor, MI and led by Gerry McCarthy, the former CEO of eSolutions, another Francisco portfolio company.]
IBM is divesting its Watson Health business to focus more resources on its platform-based hybrid cloud and artificial intelligence technologies.
The brunt of the tariff exposure stems from Singapore and Costa Rica, which together account for an estimated 70% to 80% of the tariff-related cost burden. Less than 10% of the exposure is tied to China.
A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
